文献速递糖尿病肥胖与代谢综合征

美国年轻成人发病的2型糖尿病诊断发病率及危险因素:2016-2022年美国全国健康访谈调查

Incidence and Risk Factors of Diagnosed Young-Adult-Onset Type 2 Diabetes in the U.S.: The National Health Interview Survey 2016-2022.
PubMed 文献 · Diabetes Care · 2025-01-01

该研究分析2016-2022年美国全国健康访谈调查中142,884名18-79岁自我报告糖尿病类型的成人,估算年轻成人发病(18-44岁)2型糖尿病的诊断发病率为3.0/1000成人(95%CI 2.6-3.5),并发现降脂药使用(aOR 13.15)、降压药使用(aOR 11.89)和肥胖(BMI≥30 vs <25 kg/m2,aOR 10.89)是最强危险因素,且这些因素与年轻成人发病2型糖尿病的关联比晚发2型糖尿病更强(aOR最高达4.5倍)。结论指出需针对少数族裔、社会经济弱势人群及心血管代谢疾病患者制定年轻成人发病2型糖尿病的针对性预防策略。

要点

  • 年轻成人发病2型糖尿病诊断发病率为3.0/1000成人(95%CI 2.6-3.5)。
  • 降脂药使用aOR 13.15、降压药使用aOR 11.89、肥胖aOR 10.89为最强危险因素。
  • 上述危险因素及高血压、高脂血症、冠心病与年轻成人发病2型糖尿病的关联比晚发2型糖尿病更强,aOR最高达4.5倍。

核心结论

  • 本研究量化了美国成人年轻成人发病2型糖尿病的诊断发病率,并识别出其独特的危险因素特征。
  • 需要针对少数族裔、社会经济弱势人群及心血管代谢疾病患者制定年轻成人发病2型糖尿病的针对性预防策略。

研究设计与样本

  • 横断面研究,分析2016-2022年美国全国健康访谈调查中142,884名18-79岁自我报告糖尿病类型的成人,代表非机构化的美国平民人口。
  • 按三个年龄组计算诊断2型糖尿病发病率:年轻成人发病(18-44岁)、中年发病(45-64岁)和老年成人发病(65-79岁),后两组用于突出年轻成人发病2型糖尿病的独特危险因素特征。
  • 采用多变量logistic回归识别年轻成人发病2型糖尿病的危险因素。

主要发现

  • 年轻成人发病2型糖尿病的估计诊断发病率为3.0/1000成人(95%CI 2.6-3.5)。
  • 少数族裔、社会经济弱势个体及患有心血管代谢疾病或心理状况的人群,其年轻成人发病2型糖尿病的诊断发病率高于对应参照人群。
  • 降脂药使用(aOR 13.15,95%CI 8.85-19.55)、降压药使用(aOR 11.89,95%CI 7.97-17.73)和肥胖(BMI≥30 vs <25 kg/m2,aOR 10.89,95%CI 6.69-17.7)是年轻成人发病2型糖尿病的最强危险因素。
  • 这些危险因素以及高血压、高脂血症和冠心病与年轻成人发病2型糖尿病的关联比晚发2型糖尿病更强,aOR最高达4.5倍。

关键数值与推荐

  • 年轻成人发病(18-44岁)诊断2型糖尿病发病率:3.0/1000成人(95%CI 2.6-3.5)。
  • 降脂药使用与年轻成人发病2型糖尿病:aOR 13.15(95%CI 8.85-19.55)。
  • 降压药使用与年轻成人发病2型糖尿病:aOR 11.89(95%CI 7.97-17.73)。
  • 肥胖(BMI≥30 vs <25 kg/m2)与年轻成人发病2型糖尿病:aOR 10.89(95%CI 6.69-17.7)。
  • 上述危险因素及高血压、高脂血症、冠心病与年轻成人发病2型糖尿病的aOR最高达晚发2型糖尿病的4.5倍。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To estimate the incidence and identify risk factors for diagnosed type 2 diabetes (T2D) among young U.S. adults. RESEARCH DESIGN AND METHODS: We analyzed 142,884 adults aged 18-79 years with self-reported diabetes type from the cross-sectional National Health Interview Survey in 2016-2022, representing the noninstitutionalized U.S. civilian population. Incidence of diagnosed T2D was calculated for three age groups: young-adult onset (18-44 years), middle-age onset (45-64 years), and older-adult onset (65-79 years); the latter two groups were included to highlight the distinct risk factor profile of young-adult-onset T2D. Multivariable logistic regressions were used to identify risk factors for young-adult-onset T2D. RESULTS: The estimated incidence of diagnosed young-adult-onset T2D was 3.0 per 1,000 adults (95% CI 2.6-3.5). Minority groups, socioeconomically disadvantaged individuals, and people with cardiometabolic diseases or psychological conditions had a higher incidence of diagnosed young-adult-onset T2D compared with their counterparts. Lipid-lowering medication use (adjusted odds ratio [aOR] 13.15, 95% CI 8.85-19.55), antihypertensive medication use (aOR 11.89, 95% CI 7.97-17.73), and obesity (BMI ≥30 vs. <25 kg/m2, aOR 10.89, 95% CI 6.69-17.7) were the strongest risk factors for young-adult-onset T2D; these risk factors, along with hypertension, hyperlipidemia, and coronary heart disease, were more strongly associated with young-adult-onset T2D compared with later-onset T2D, with up to 4.5 times higher aORs. CONCLUSIONS: This study quantified the incidence of diagnosed young-adult-onset T2D in U.S. adults and identified its distinct risk factor profile. Targeted prevention strategies for young-adult-onset T2D are needed for minority and socioeconomically disadvantaged people and those with cardiometabolic diseases.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Xu L, Ran J, Shao H, et al. Incidence and Risk Factors of Diagnosed Young-Adult-Onset Type 2 Diabetes in the U.S.: The National Health Interview Survey 2016-2022. Diabetes Care. 2025. PMID: 39752552. doi:10.2337/dc24-1699

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。